A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast ...
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast ...
EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening ...
5d
Science for living: Can using AI risk prediction in breast cancer screening improve early detection?
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...
Breast cancer among AAPI women under 50 surged 52% since 2000. Immigration, westernization, and cultural barriers to screening put Indian American women at hidden risk—but disaggregated data is scarce ...
Nanoparticles coated with the molecular sensors could be used in at-home diagnostics. Researchers at MIT and Microsoft have used artificial intelligence to create molecular sensors that could detect ...
AURORA, Colorado — Researchers at the CU Anschutz Cancer Center have launched a clinical trial funded by the National Cancer Institute that will evaluate blood tests that could detect a number of ...
Mammograms can detect the presence of breast arterial calcification, which is associated with a higher risk of future heart attacks and stroke. Mammograms detect tumors, but they can also identify ...
The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital ...
Breast cancer is one of the most common cancers in the world. Early detection greatly improves the chances of successful treatment, and frequent screenings are especially important for people at high ...
Artificial intelligence (AI)-supported mammography identifies more cancers during screening and reduces the rate of breast cancer diagnosis by 12% in the years following, finds the first randomised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results